Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSinclair Pharma Regulatory News (SPH)

  • There is currently no data for SPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

17 Jan 2018 07:00

RNS Number : 0601C
Sinclair Pharma PLC
17 January 2018
 

Sinclair Pharma plc

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

London, 17 January 2018 Sinclair Pharma plc (AIM:SPH.L) ("Sinclair" or the "Group"), the international aesthetics company, was advised on 16 January 2018, that on that day, Jeff Thompson, Non-Executive Director, acquired 200,000 ordinary shares of 1p each ("Ordinary Shares") in the Group at an average price of 23.1p per Ordinary Share.

Following these purchases, Jeff Thompson's total beneficial interest is 350,000 Ordinary Shares, 0.07% of the issued share capital of the Group.

For further information please contact:

Sinclair Pharma plc

Tel: +44 (0) 20 7467 6920

Chris Spooner 

Alan Olby

Andy Crane

 

Peel Hunt LLP (NOMAD and Joint Broker)

Tel: +44 (0) 20 7418 8900

James Steel

Oliver Jackson

 

RBC Capital Markets (Joint Broker)

Tel: +44 (0) 20 7653 4000

Marcus Jackson

Laura White

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Jeff Thompson

2.

Reason for the notification

a.

Position/status

Non-Executive Director

b.

Initial notification

/Amendment

Initial Announcement

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Sinclair Pharma plc

b.

LEI

213800BNMD7JVMHW1772

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type

of instrument

Identification code

Ordinary Shares of 1 pence each in Sinclair Pharma plc

 

 

 

GB0033856740

b.

Nature of the transaction

Purchase

 

c.

Price(s) and volume(s)

 Price(s)

 

Volume(s)

23.1p

200,000

d.

Aggregated information

· Aggregated volume

· Price

 

 

N/A

 

e.

Date of the transaction

2018-01-16

f.

Place of the transaction

London Stock Exchange, AIM

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHDQLFFVFFLBBD
Date   Source Headline
18th Mar 20163:52 pmRNSRobert Stuart Swanson - Form 8.3 - Sinclair Pharma
18th Mar 201612:10 pmBUSForm 8.3 - Sinclair Pharma Plc
18th Mar 201611:02 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
17th Mar 20163:13 pmRNSForm 8.3 - SINCLAIR PHARMA PLC
17th Mar 201610:42 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
16th Mar 20163:08 pmRNSForm 8.3 - SINCLAIR PHARMA PLC
16th Mar 20168:32 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
15th Mar 20162:53 pmRNSForm 8.3 - SINCLAIR PHARMA PLC
15th Mar 201611:36 amBUSForm 8.3 - Sinclair Pharma Plc
15th Mar 20167:30 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
14th Mar 20161:34 pmRNSForm 8.3 - SINCLAIR PHARMA PLC
14th Mar 20168:45 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
11th Mar 20163:22 pmRNSForm 8.3 - SINCLAIR PHARMA PLC
10th Mar 20168:43 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
9th Mar 201611:59 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma PLC
7th Mar 20169:56 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
4th Mar 201611:59 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
3rd Mar 201611:42 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
2nd Mar 201611:25 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
1st Mar 201610:20 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
29th Feb 201611:12 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
29th Feb 201611:11 amBUSForm 8.3 - Sinclair Pharma Plc
25th Feb 20162:07 pmRNSForm 8.3 - SINCLAIR PHARMA PLC
25th Feb 20161:34 pmRNSForm 8.3 - [Sinclair Pharma plc]
25th Feb 20169:40 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
24th Feb 20163:13 pmRNSForm 8.3 - [Sinclair Pharma plc]
24th Feb 20168:47 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
23rd Feb 201611:59 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
19th Feb 20161:32 pmRNSForm 8.3 - [Sinclair Pharma plc]
19th Feb 20167:47 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
18th Feb 20161:27 pmRNSForm 8.3 - [Sinclair Pharma plc]
18th Feb 201611:59 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
17th Feb 201612:53 pmRNSForm 8.3 - [Sinclair Pharma plc]
17th Feb 201611:49 amBUSForm 8.3 - Sinclair Pharma Plc
17th Feb 20168:25 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
15th Feb 20163:11 pmRNSForm 8.3 - [Sinclair Pharma plc]
15th Feb 201611:59 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
12th Feb 20163:15 pmRNSForm 8.3 - [Sinclair Pharma plc]
12th Feb 201612:01 pmBUSForm 8.3 - Sinclair Pharma Plc
12th Feb 201611:59 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
11th Feb 201611:59 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
11th Feb 201610:54 amRNSHolding(s) in Company
10th Feb 20169:24 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
9th Feb 20162:55 pmRNSForm 8.3 - [Sinclair Pharma plc]
9th Feb 201611:59 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
8th Feb 20162:08 pmRNSForm 8.3 - [Sinclair Pharma plc]
8th Feb 20168:10 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
5th Feb 20162:42 pmRNSForm 8.3 - [Sinclair Pharma plc]
5th Feb 201611:59 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
4th Feb 20162:59 pmRNSForm 8.3 - [Sinclair Pharma plc]

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.